🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multicenter, prospective, randomized phase II trial aimed a...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2024-03-01
Trial ID
NCT06272214
Treatments Being Tested
In this study, investigators utilize a radiopathomics integrated Artificial...
Status
Unknown
Location
Gastrointestinal Department of First Affiliated Hospital of Zhejiang University
Start Date
2024-07-01
Trial ID
NCT06396143
This phase II trials studies how well pembrolizumab and vactosertib work af...
Status
Terminated
Location
University of California, San Francisco
Start Date
2019-07-22
Trial ID
NCT03844750
Treatments Being Tested
This study aims to observe and evaluate the efficacy and safety of the peri...
Status
Terminated
Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2020-12-26
Trial ID
NCT04653389
Treatments Being Tested
This phase II trial studies how well dabrafenib, trametinib, and spartalizu...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2020-01-29
Trial ID
NCT04310397
Treatments Being Tested
This study is being done to learn more about a new medicine called PF-08634...
Status
Recruiting
Location
Clearview Cancer Institute (Crestwood)
Start Date
2026-06-30
Trial ID
NCT07489066
Treatments Being Tested
The IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with T...
Status
Recruiting
Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Start Date
2026-05-06
Trial ID
NCT07571551
Treatments Being Tested
This is a multicenter, single-arm, phase II clinical study evaluating the e...
Status
Enrolling By Invitation
Location
The First People's Hospital of Foshan
Start Date
2026-04-20
Trial ID
NCT07618624
This is an open-label, multicenter, single-arm Phase 2 clinical trial evalu...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-08-15
Trial ID
NCT07767266
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of pembrol...
Status
Recruiting
Location
Department of minimally invasive esophageal surgery, Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-12-01
Trial ID
NCT04807673
Treatments Being Tested